Cupertino, CA-based Minerva Surgical, which is developing a medical device for treating abnormal uterine bleeding in women, has raised $26.2 million in an offering of equity, options, and securities, according to a June 2 regulatory filing. Minerva’s investors are not identified in the filing, but board directors include Ali Behbahani and John Nehra of New Enterprise Associates and Ross Jaffe of Versant Ventures. David Auth, a Seattle-based medical device pioneer, is also on Minerva’s board.
